1.Low Molecular Weight Heparin Treatment in Pregnant Women with a Mechanical Heart Valve Prosthesis.
Jae Hoon LEE ; Nam Hee PARK ; Dong Yoon KEUM ; Sae Young CHOI ; Ki Young KWON ; Chi Heum CHO
Journal of Korean Medical Science 2007;22(2):258-261
No definitive recommendation is available concerning optimal antithrombotic therapy in pregnant women with a mechanical heart valve. The purpose of the current study was to evaluate the clinical results of nadroparin treatment with respect to pregnancy outcome and maternal complications. From 1997 to 2005, 31 pregnancies were reviewed in 25 women. Nadroparin (7,500 U, twice daily) was used in 23 pregnancies between 6 and 12 weeks of gestation and close-to-term only, and coumarin derivatives were used with aspirin at other times. Eight pregnant women treated with coumarin derivatives throughout pregnancy were compared to evaluate the safety and efficacy of nadroparin. No maternal death or bleeding complication occurred in either of the two groups, and frequencies of maternal thromboembolism including valve thrombosis (8.7% vs. 12.5%, p>0.05) were similar. However, the frequencies of live born (91.3% vs. 50%, p=0.01) and healthy babies (90.4% vs. 25%, p<0.01) were significantly higher, and the fetal loss rate was significantly lower (8.7% vs. 50%, p=0.01) in the nadroparin-treated group. Regarding the efficacy and safety of antithrombotic treatment in pregnant women with prosthetic heart valves, nadroparin treatment during the first trimester is an acceptable regimen and produces better results than coumarin derivatives.
Treatment Outcome
;
Thrombosis/etiology/*prevention & control
;
Pregnancy Outcome
;
Pregnancy Complications, Cardiovascular/*etiology/*prevention & control
;
Pregnancy
;
Nadroparin/*administration & dosage/*adverse effects
;
Hydrocephalus/chemically induced
;
Humans
;
Heart Valve Prosthesis/*adverse effects
;
Heart Valve Diseases/etiology/*prevention & control
;
Female
;
Coumarins/administration & dosage
;
Adult
2.A pre-conception cohort to study preeclampsia in China: Rationale, study design, and preliminary results.
Shiwu WEN ; Hongzhuan TAN ; Rihua XIE ; Graeme N SMITH ; Mark WALKER
Journal of Central South University(Medical Sciences) 2012;37(11):1081-1087
OBJECTIVE:
It is uncertain whether preeclampsia (PE) is caused by pre-existing factors or by pregnancy itself. We want to answer this important question in public health by conducting a large pre-conception cohort in China.
METHODS:
A prospective and pre-conception cohort study with a target recruitment of 5000 couples who plan to have a baby within 6 months was performed and their conception, delivery, and postpartum were followed up in Liuyang county, Hunan Province of P. R. China.
RESULTS:
A total of 1915 young couples have been recruited into this unique pre-conception cohort till now. In general, both systolic blood pressure and diastolic blood pressure decreased in early second trimester from pre-conception level but increased in third trimester and at delivery.
CONCLUSION
The proposed pre-conception cohort study will have important theoretical and practical implications on the prevention of PE and its associated cardiovascular disease risks.
Adult
;
Blood Pressure
;
physiology
;
China
;
Female
;
Humans
;
Pre-Eclampsia
;
etiology
;
physiopathology
;
prevention & control
;
Pregnancy
;
Pregnancy Complications, Cardiovascular
;
physiopathology
;
prevention & control
;
Prospective Studies
;
Young Adult